PHASE-II STUDY OF IFOSFAMIDE-ETOPOSIDE-MESNA IN ADULTS WITH ADVANCED NONOSSEOUS SARCOMAS

被引:21
|
作者
EDMONSON, JH
BUCKNER, JC
LONG, HJ
LOPRINZI, CL
SCHAID, DJ
机构
关键词
D O I
10.1093/jnci/81.11.863
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:863 / 866
页数:4
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN MIXED MESODERMAL TUMORS OF THE UTERUS (A GYNECOLOGIC-ONCOLOGY-GROUP-STUDY)
    SUTTON, GP
    BLESSING, JA
    ROSENSHEIN, N
    PHOTOPULOS, G
    DISAIA, PJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (02) : 309 - 312
  • [42] A PHASE-II STUDY OF IFOSFAMIDE IN ENDOMETRIAL CANCER
    BARTON, C
    BUXTON, EJ
    BLACKLEDGE, G
    MOULD, JJ
    MEANWELL, CA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S4 - S6
  • [43] EPIRUBICIN AND IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMA - A PHASE-II STUDY
    CHEVALLIER, B
    LEYVRAZ, S
    OLIVIER, JP
    FARGEOT, P
    FACCHINI, T
    VAN, MLV
    CANCER INVESTIGATION, 1993, 11 (02) : 135 - 139
  • [44] PHASE-II STUDY OF IFOSFAMIDE + ADRIAMYCIN IN ADVANCED SOFT-TISSUE SARCOMA IN ADULTS - A PRELIMINARY-ANALYSIS
    DOMBERNOWSKY, P
    MOURIDSEN, H
    SCHUTTE, J
    SANTORO, A
    ROUESSE, J
    SOMERS, R
    STEWART, W
    PINEDO, HM
    VANOOSTEROM, A
    BLACKLEDGE, G
    THOMAS, D
    SYLVESTER, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S17 - S17
  • [45] CHLOROZOTOCIN - PHASE-II EVALUATION IN PATIENTS WITH ADVANCED SARCOMAS
    SORDILLO, PP
    MAGILL, GB
    GRALLA, RJ
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 513 - 514
  • [46] A PHASE-II TRIAL OF DOSE-ESCALATED DOXORUBICIN AND IFOSFAMIDE MESNA IN PATIENTS WITH MALIGNANT MESOTHELIOMA
    DIRIX, LY
    VANMEERBEECK, J
    SCHRIJVERS, D
    CORTHOUTS, B
    PROVE, A
    VANMARCK, E
    VERMEIRE, P
    VANOOSTEROM, AT
    ANNALS OF ONCOLOGY, 1994, 5 (07) : 653 - 655
  • [47] PHASE-II STUDY OF RAPID-SCHEDULED ETOPOSIDE IN PEDIATRIC SOFT-TISSUE SARCOMAS
    PHILLIPS, MB
    FLAMANT, F
    SOMMELETOLIVE, D
    PINKERTON, CR
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 782 - 784
  • [48] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    DISAIA, PJ
    CHRISTOPHERSON, WA
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 661 - 662
  • [49] First line therapy with aldoxorubicin and 14 days continuous infusion of ifosfamide/mesna in metastatic or locally advanced sarcomas: a phase I-II study
    Chawla, S. P.
    Sankhala, K.
    Chawla, S.
    Chua, V.
    Gordon, E. M.
    Chawla, N.
    Sung, K.
    Quon, D.
    Kim, K.
    Fernandez, L.
    Leong, B.
    Wieland, S.
    Levitt, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] IFOSFAMIDE AND ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS
    BLAIR, SC
    ZALUPSKI, MM
    BAKER, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06): : 480 - 484